A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer

Carol Aghajanian, Virginia L. Filiaci, Don S. Dizon, Jay W. Carlson, Matthew A. Powell, Angeles Alvarez Secord, Krishnansu S. Tewari, David Bender, David M. O’Malley, Ashley Stuckey,

Gynecologic Oncology · 2018 · 138 citations · 25 references

Concepts

References

25